Terug
Dagbereik
€ 36,22
€ 90,00
52-Weeksbereik
€ 10,24
€ 90,00
Volume
10
50D / 200D Gem.
€ 10,24
/
€ 10,30
Vorige Slotkoers
€ 10,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -13,1 | 0,3 |
| P/B | 5,2 | 2,9 |
| ROE % | -34,9 | 3,7 |
| Net Margin % | -12,0 | 3,8 |
| Rev Growth 5Y % | -10,2 | 10,0 |
| D/E | 0,9 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,44
€ 0,42 – € 0,48
|
1,9 B | 1 |
| FY2029 |
-€ 0,05
-€ 0,06 – -€ 0,05
|
1,7 B | 1 |
| FY2028 |
-€ 0,28
-€ 0,31 – -€ 0,27
|
1,5 B | 1 |
Belangrijkste Punten
Revenue declined -10,15% annually over 5 years
Negative free cash flow of -55,21M
PEG of 0,05 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20,77%
Capital efficient — spends only 2,54% of revenue on capex
Groei
Revenue Growth (5Y)
-10,15%
Revenue (1Y)10,62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-34,90%
ROIC-11,15%
Net Margin-11,95%
Op. Margin-8,62%
Veiligheid
Debt / Equity
0,92
Current Ratio1,83
Interest Coverage0,00
Waardering
P/E Ratio
-13,09
P/B Ratio5,18
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,62% | Revenue Growth (3Y) | 7,73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -10,15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,13B | Net Income (TTM) | -134,46M |
| ROE | -34,90% | ROA | -17,28% |
| Gross Margin | 0,00% | Operating Margin | -8,62% |
| Net Margin | -11,95% | Free Cash Flow (TTM) | -55,21M |
| ROIC | -11,15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,92 | Current Ratio | 1,83 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -13,09 | P/B Ratio | 5,18 |
| P/S Ratio | 1,56 | PEG Ratio | 0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,76B | Enterprise Value | 1,98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,13B | 1,02B | 969,46M | 930,97M | 1,73B |
| Net Income | -134,46M | -97,25M | 82,28M | -171,12M | -225,74M |
| EPS (Diluted) | -2,60 | -8,25 | -10,07 | -15,88 | -23,40 |
| Gross Profit | 0,0 | 216,54M | 203,35M | 160,15M | 260,05M |
| Operating Income | -96,95M | -104,22M | 89,70M | 40,49M | 106,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 778,13M | 866,42M | 1,10B | 1,27B | 1,28B |
| Total Liabilities | 438,02M | 435,89M | 748,67M | 784,29M | 746,74M |
| Shareholders' Equity | 340,11M | 430,53M | 350,78M | 484,92M | 531,74M |
| Total Debt | 312,21M | 330,82M | 528,64M | 525,15M | 526,43M |
| Cash & Equivalents | 95,37M | 54,03M | 126,04M | 277,74M | 300,61M |
| Current Assets | 213,57M | 293,67M | 395,88M | 537,14M | 539,27M |
| Current Liabilities | 116,48M | 180,32M | 241,35M | 212,54M | 156,66M |